Siglec-6 on Chronic Lymphocytic Leukemia Cells Is a Target for Post-Allogeneic Hematopoietic Stem Cell Transplantation Antibodies
Cancer immunology research - United States
doi 10.1158/2326-6066.cir-18-0102
Full Text
Open PDFAbstract
Available in full text
Date
July 6, 2018
Authors
Publisher
American Association for Cancer Research (AACR)